GC Biopharma, formerly known as Green Cross Corporation, is a South Korean biopharmaceutical company headquartered in Yongin, South Korea. Established in 1967, it specializes in the development, manufacturing, and marketing of vaccines, plasma-derived therapies, and mRNA therapeutics. The company has made significant contributions to global healthcare, particularly in the areas of blood products and vaccines for hepatitis, influenza, and other diseases. With a focus on innovation, GC Biopharma continues to expand its research into emerging fields like mRNA technology and rare diseases. Its commitment to improving public health has earned it recognition in international markets.